Phreesia (NYSE:PHR – Get Free Report)‘s stock had its “neutral” rating reaffirmed by stock analysts at JPMorgan Chase & Co. in a report released on Tuesday, MarketBeat.com reports. They presently have a $16.00 price objective on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 39.93% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Canaccord Genuity Group cut their price objective on shares of Phreesia from $38.00 to $33.00 and set a “buy” rating on the stock in a research note on Tuesday, December 9th. Citigroup reiterated a “neutral” rating and issued a $10.00 target price on shares of Phreesia in a research report on Tuesday. Needham & Company LLC dropped their price target on shares of Phreesia from $35.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday. Wells Fargo & Company dropped their price objective on Phreesia from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday, March 26th. Finally, Truist Financial reaffirmed a “hold” rating and set a $11.00 target price on shares of Phreesia in a report on Tuesday. Thirteen research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $22.71.
Get Our Latest Stock Analysis on Phreesia
Phreesia Stock Up 4.1%
Phreesia (NYSE:PHR – Get Free Report) last announced its quarterly earnings results on Monday, March 30th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.05). Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The business had revenue of $127.07 million for the quarter, compared to analyst estimates of $126.75 million. During the same quarter last year, the firm posted ($0.11) EPS. The company’s revenue was up 15.9% compared to the same quarter last year. As a group, research analysts predict that Phreesia will post -1.1 earnings per share for the current year.
Insider Buying and Selling
In other news, CFO Balaji Gandhi sold 8,009 shares of the stock in a transaction on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total transaction of $136,233.09. Following the completion of the sale, the chief financial officer owned 156,231 shares in the company, valued at approximately $2,657,489.31. This represents a 4.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Evan Roberts sold 6,317 shares of the firm’s stock in a transaction on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total value of $107,452.17. Following the sale, the insider directly owned 834,632 shares of the company’s stock, valued at approximately $14,197,090.32. This represents a 0.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 70,358 shares of company stock worth $1,123,569 over the last three months. Corporate insiders own 5.50% of the company’s stock.
Hedge Funds Weigh In On Phreesia
A number of institutional investors have recently bought and sold shares of the stock. Federated Hermes Inc. acquired a new stake in Phreesia during the 3rd quarter worth about $32,000. Van ECK Associates Corp boosted its holdings in shares of Phreesia by 78.7% in the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after buying an additional 1,102 shares during the period. Asset Management One Co. Ltd. purchased a new position in shares of Phreesia in the third quarter worth approximately $45,000. Rockefeller Capital Management L.P. increased its position in shares of Phreesia by 354.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after acquiring an additional 2,149 shares in the last quarter. Finally, KBC Group NV raised its holdings in shares of Phreesia by 83.4% during the fourth quarter. KBC Group NV now owns 3,449 shares of the company’s stock valued at $58,000 after acquiring an additional 1,568 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.
Phreesia News Roundup
Here are the key news stories impacting Phreesia this week:
- Positive Sentiment: Company reported positive GAAP net income and strong free cash flow for the fiscal year — exceeded internal targets including crossing $100M of Adjusted EBITDA and roughly $50M+ of free cash flow, a proof point for profitability and capital-generation that can support valuation. Phreesia Announces Fourth Quarter Fiscal 2026 Results
- Positive Sentiment: Management highlighted record revenue growth and strategic initiatives on the Q4 call, indicating underlying demand and execution on product/partnership priorities that investors view as longer-term upside. Phreesia Inc (PHR) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic …
- Neutral Sentiment: Full earnings-call transcript is available for detail seekers — useful for investors who want management’s color on drivers, margin improvement, and the AccessOne integration timeline. Phreesia, Inc. (PHR) Q4 2026 Earnings Call Transcript
- Neutral Sentiment: Several analysts revised expectations heading into the print, lowering EPS/forecast assumptions — shows sentiment was already shifting and likely amplified intraday moves. Top Wall Street Forecasters Revamp Phreesia Expectations Ahead Of Q4 Earnings
- Negative Sentiment: Management cut near-term outlook: FY2027 revenue was guided to $510M–$520M and executives warned of headwinds from the network solutions business and integration-related pressure from AccessOne — a driver of the recent sell-off. Phreesia outlines $510M–$520M revenue target for 2027 amid network solutions headwinds and AccessOne integration
- Negative Sentiment: Market reaction: shares plunged after the EPS miss and guidance cut (reports of a ~22% drop and all-time lows in some sessions) — short-term momentum and sentiment risk remain. Phreesia shares tumble 22% on earnings miss, slashed guidance
Phreesia Company Profile
Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.
See Also
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
